Literature DB >> 5696549

Treatment of oral cancer.

.   

Abstract

Entities:  

Mesh:

Year:  1968        PMID: 5696549      PMCID: PMC1912108     

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


× No keyword cloud information.
  9 in total

1.  CARCINOMA OF THE TONGUE.

Authors:  G S SHARP; J T HELSPER
Journal:  Am J Surg       Date:  1964-10       Impact factor: 2.565

2.  COMBINED IRRADIATION AND CHEMOTHERAPY IN THE TREATMENT OF SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK.

Authors:  M FRIEDMAN; J F DALY
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1963-08

3.  Cancer of the tongue. Report of the management of 1,554 patients.

Authors:  E L FRAZELL; J C LUCAS
Journal:  Cancer       Date:  1962 Nov-Dec       Impact factor: 6.860

4.  Cancer of the tongue; a study based on 653 patients.

Authors:  S CADE; E S LEE
Journal:  Br J Surg       Date:  1957-03       Impact factor: 6.939

5.  The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy.

Authors:  L H GRAY; A D CONGER; M EBERT; S HORNSEY; O C SCOTT
Journal:  Br J Radiol       Date:  1953-12       Impact factor: 3.039

6.  Some observations on the combined effects of x-rays and methotrexate on human tumor cells in vitro with possible relevance to their most useful combination in radiotherapy.

Authors:  R J Berry
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-03

7.  Cancer chemotherapy by continuous intra-arterial infusion of methotrexate.

Authors:  J I Burn; I D Johnston; A J Davies; R A Sellwood
Journal:  Br J Surg       Date:  1966-04       Impact factor: 6.939

8.  Ten year survey of oral cancer in a general hospital.

Authors:  D P Shedd; C F von Essen; A G Bevin; R A Greenberg
Journal:  Am J Surg       Date:  1967-12       Impact factor: 2.565

9.  The influence of histological grading on prognosis in carcinoma of the tongue (a computer analysis of 299 cases).

Authors:  J F Arthur; M L Fenner
Journal:  Clin Radiol       Date:  1966-10       Impact factor: 2.350

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.